These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25416535)

  • 21. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
    Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest.
    Bělohlávek J; Springer D; Mlček M; Huptych M; Bouček T; Hodková G; Fichtl J; Mrázek V; Zima T; Linhart A; Kittnar O
    Pulm Pharmacol Ther; 2013 Dec; 26(6):655-60. PubMed ID: 23524014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
    Shekar K; Roberts JA; Barnett AG; Diab S; Wallis SC; Fung YL; Fraser JF
    Crit Care; 2015 Dec; 19():437. PubMed ID: 26667471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
    Amaker RD; DiPiro JT; Bhatia J
    Antimicrob Agents Chemother; 1996 May; 40(5):1139-42. PubMed ID: 8723454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation.
    Yang S; Noh H; Hahn J; Jin BH; Min KL; Bae SK; Kim J; Park MS; Hong T; Wi J; Chang MJ
    Sci Rep; 2017 Nov; 7(1):16276. PubMed ID: 29176598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.
    Baptista JP; Roberts JA; Sousa E; Freitas R; Deveza N; Pimentel J
    Crit Care; 2014 Dec; 18(6):654. PubMed ID: 25475123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.
    Touchard C; Aubry A; Eloy P; Bréchot N; Lebreton G; Franchineau G; Besset S; Hékimian G; Nieszkowska A; Leprince P; Luyt CE; Combes A; Schmidt M
    Crit Care; 2018 Aug; 22(1):199. PubMed ID: 30121083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.
    Lemaitre F; Hasni N; Leprince P; Corvol E; Belhabib G; Fillâtre P; Luyt CE; Leven C; Farinotti R; Fernandez C; Combes A
    Crit Care; 2015 Feb; 19(1):40. PubMed ID: 25886890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.
    Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J
    Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
    Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report].
    He N; Yan YY; Ying YQ; Yi M; Yao GQ; Ge QG; Zhai SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):915-920. PubMed ID: 30337758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
    Cervantes FC; Mizuno T; Dong M; Tang P; Arbough T; Vinks AA; Kaplan JM; Tang Girdwood SC
    Ther Drug Monit; 2023 Dec; 45(6):832-836. PubMed ID: 37725684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic Outcomes of Extracorporeal Membrane Oxygenation With and Without Ambulation as a Bridge to Lung Transplantation.
    Bain JC; Turner DA; Rehder KJ; Eisenstein EL; Davis RD; Cheifetz IM; Zaas DW
    Respir Care; 2016 Jan; 61(1):1-7. PubMed ID: 26264415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance.
    Lin Wu FL; Liu SS; Yang TY; Win MF; Lin SW; Huang CF; Wang KC; Shen LJ
    Ther Drug Monit; 2015 Oct; 37(5):609-18. PubMed ID: 25627406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex Vivo Model to Decipher the Impact of Extracorporeal Membrane Oxygenation on Beta-lactam Degradation Kinetics.
    Leven C; Fillâtre P; Petitcollin A; Verdier MC; Laurent J; Nesseler N; Launey Y; Tattevin P; Bellissant E; Flécher E; Lemaitre F
    Ther Drug Monit; 2017 Apr; 39(2):180-184. PubMed ID: 28033162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
    Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
    Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.